Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome

NCT02082067 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-08-09

No results posted yet for this study

Summary

Aim of this study is to evaluate the effects of the adductor canal block on the early and medium term ( 1 month) rehabilitation compared to the continuous femoral block commonly used in the knee prosthesis.

Conditions

  • Total Knee Arthroplasty

Interventions

PROCEDURE

Adductor canal

Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert in adductor canal through tuohy needle (18G, 100mm length) under ultrasound guidance.

PROCEDURE

Femoral

Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert between femoral nerve and femoral artery through tuohy needle (18G, 100mm length) under ultrasound guidance.

PROCEDURE

Spinal Anesthesia

Spinal anesthesia will be perform at L3-L4 or L4-L5 level. Levobupivacaine 0,5% 12mg will be injected.

PROCEDURE

Local anesthetic infusion

Continuous infusion of levobupivacaine 0,125% at 8ml/h rate through perinervous catheter until 5th postoperative day.

PROCEDURE

Intravenous analgesia

Ketorolac 30mg 3 times/day and morphine Patients Control Analgesia (1mg/h, max 4mg/h) administered.

DRUG

Ropivacaine 0,75%

DRUG

Levobupivacaine 0,5%

DRUG

Levobupivacaine 0,125%

DRUG

Ketorolac 30mg

DRUG

Morphine

DEVICE

stimulong sono, Pajunk, Germany

Sponsors & Collaborators

  • ASST Gaetano Pini-CTO

    lead OTHER

Principal Investigators

  • Gianluca Cappelleri, M.D. · ASST Gaetano Pini-CTO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-09-30
Completion
2016-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082067 on ClinicalTrials.gov